与体重维持相关的有机化合物的暴露
Research square
|January 9, 2026
概括
暴露于某些有机化合物,如总PCB,可能与肥胖的成年人体重增加有关. 然而,p,p-DDE与较低的体重存在关联,这表明了复杂的污染物影响.
科学领域:
- 环境健康 环境健康
- 内分泌学 在内分泌学.
- 肥胖问题研究研究
背景情况:
- 有机化合物是持久性环境污染物.
- 肥胖是一种复杂的代谢障碍,具有多因素的原因.
- 饮食干预是体重管理的常见策略.
研究的目的:
- 调查有机化合物暴露与体重变化之间的关联.
- 测试有机素有助于肥胖成人的体重增加的假设.
- 在饮食干预研究的背景下分析这些关联.
主要方法:
- 在DioGenes试验中,在基线时对血有机化合物度的分析.
- 包括肥胖的成年人,他们经历了显著的体重减轻和26周的饮食干预.
- 对有机含量与体重变化之间的关联进行统计评估,并对共变量和PFAS暴露进行调整.
主要成果:
- 血中多双 (PCB) 总量的翻倍与26周体重增加0.43公斤相关.
- 大多数单独的有机都显示出相同的趋势,但经过调整后缺乏统计学意义.
- 而p,p'-DDE则表现出相反的相关性,与体重减轻有关.
结论:
- 一些有机化合物的含量升高与体重增加有微弱的关联,但在调整后的重要性有所不同.
- p,p'-DDE度明显与体重减轻有关.
- 这些化污染物可能在肥胖大流行中发挥作用.
相关概念视频
Types of Toxins
3.1K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
The Periodic Table and Organismal Elements
22.1K
Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
Periodic Table Provides Information...
22.1K
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165


